Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC)

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Abstract

Degenerative and traumatic articular cartilage defects are common, difficult to treat, and progressive lesions that cause significant morbidity in the general population. There have been multiple approaches to treat such lesions, including arthroscopic debridement, microfracture, multiple drilling, osteochondral transplantation and autologous chondrocyte implantation (ACI) that are currently being used in clinical practice. Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC) is a single-staged arthroscopic procedure. This method combines a modified microfracture technique with the application of a bone marrow aspirate concentrate (BMAC), hyaluronic acid and fibrin gel to treat articular cartilage defects. We reviewed the current literatures and surgical techniques for mesenchymal cell induced chondrogenesis.

Original languageEnglish
Pages (from-to)153-156
Number of pages4
JournalJournal of Clinical Orthopaedics and Trauma
Volume7
Issue number3
DOIs
StatePublished - 1 Sep 2016

Bibliographical note

Publisher Copyright:
© 2016

Keywords

  • Arthrosis
  • Bone marrow aspirate concentrate
  • Cartilage
  • Chondral defect
  • Knee arthroscopy

Fingerprint

Dive into the research topics of 'Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC)'. Together they form a unique fingerprint.

Cite this